Pyxis Oncology (PYXS) Earnings Date & Reports

Pyxis Oncology Inc is a clinical-stage oncology company focused on developing therapies for patients with solid tumors, with an initial emphasis on head and neck squamous cell carcinoma... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PYXS is expected to report earnings to fall 4.22% to -35 cents per share on August 19

Pyxis Oncology PYXS Stock Earnings Reports

Q2'26

Est.

$-0.35

Q1'26

Est.

$-0.37

Q4'25

Missed

by $0.95

Q3'25

Missed

by $0.01

Q2'25

Beat

by $0.04

The last earnings report on May 14 showed earnings per share of -37 cents, meeting the estimate of -37 cents. With 145.76K shares outstanding, the current market capitalization sits at 135.26M.

View a ticker or compare two or three

Compare

PYXS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PYXS